4
Changes in Ownership
Mineralys Therapeutics, Inc. Filed Acc 0001933414-25-000004
Chief Medical Officer acquired 11,367 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Rodman David Malcom Chief Medical Officer | 2025-01-13 | Option exercise | +5,018 | $0.54 | $2,710 | 151,823 | D |
| Rodman David Malcom Chief Medical Officer | 2025-01-13 | Option exercise | +6,349 | $1.08 | $6,857 | 158,172 | D |
| Derivatives | |||||||
| Rodman David Malcom Chief Medical Officer | 2025-01-13 | Option exercise · Stock Option | −5,018 | 0 | D | ||
| Rodman David Malcom Chief Medical Officer | 2025-01-13 | Option exercise · Stock Option | −6,349 | 128,577 | D | ||
Loading xslF345X05/wk-form4_1736995524.xml…